Drug application
NAVSTEL (CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE and 5 more)
Drugs@FDA NDA 022193 · ALCON PHARMS LTD
Key facts
| Drug name | NAVSTEL |
|---|---|
| Active ingredients | CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE, OXIGLUTATIONE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE, SODIUM PHOSPHATE |
| Application type | NDA |
| Application number | 022193 |
| Company | ALCON PHARMS LTD |
| Dosage forms | SOLUTION, IRRIGATION |
| Strength | 0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Jul 24, 2008 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: